TFA
NVO

Toth Financial Advisory’s Novo Nordisk NVO Stock Holding History

Toth Financial Advisory’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.06K Buy
+28
New +$1.29K ﹤0.01% 945
2024
Q4 		– Sell
-11
Closed -$1.31K – 737
2024
Q3 		$1.31K Hold
11
– – ﹤0.01% 652
2024
Q2 		$1.57K Hold
11
– – ﹤0.01% 637
2024
Q1 		$1.41K Buy
+11
New +$1.31K ﹤0.01% 652
2020
Q3 		– Sell
-8,000
Closed -$262K – 588
2020
Q2 		$262K Buy
+8,000
New +$255K 0.06% 158

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Toth Financial Advisory's NVO Position: Q3 2026 in Review

Toth Financial Advisory opened a new position in Novo Nordisk (NVO) in Q3 2026: 28 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #945 among its holdings. This is a return to the name: Toth Financial Advisory previously reported a position in NVO as recently as Q3 2024.

Toth Financial Advisory first reported a position in NVO in Q2 2020 and has held it in 5 quarters since. The position peaked at $262K in Q2 2020. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Toth Financial Advisory held 28 shares of Novo Nordisk worth $1.06K as of Q3 2026.
  • Novo Nordisk was a new Toth Financial Advisory position in Q3 2026.
  • Novo Nordisk made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #945 holding.
  • Toth Financial Advisory first reported a position in Novo Nordisk in Q2 2020 and has held it in 5 quarters since.
  • Toth Financial Advisory's Novo Nordisk position peaked at $262K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.